Search Results - "Okugawa, Toshiharu"

Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy by Kondo, Eiji, Tabata, Tsutomu, Shiozaki, Takaya, Motohashi, Takashi, Tanida, Koji, Okugawa, Toshiharu, Ikeda, Tomoaki

“…Purpose This retrospective study examined the incidence of lymphocyst formation after retroperitoneal lymphadenectomy in patients with gynecologic malignancy…”
Get full text

Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer by Shiozaki, Takaya, Tabata, Tsutomu, Ma, Nei, Yamawaki, Takaharu, Motohashi, Takashi, Kondo, Eiji, Tanida, Kouji, Okugawa, Toshiharu, Ikeda, Tomoaki

“…Although CXC chemokine receptor type 4 (CXCR4) is known to be expressed in various solid tumors and plays an integral role in cancer invasion and metastasis,…”
Get more information

Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy by Ikuta, Yasushi, Katayama, Naoyuki, Wang, Lijie, Okugawa, Toshiharu, Takahashi, Yoshiyuki, Schmitt, Michael, Gu, Xiaogang, Watanabe, Masato, Akiyoshi, Kazunari, Nakamura, Hideo, Kuribayashi, Kagemasa, Sunamoto, Junzo, Shiku, Hiroshi

“…Recognition of the essential role of dendritic cells (DCs) as professional antigen-presenting cells has prompted investigators to search for methods to use DCs…”
Get full text

Torsion of a Hydrosalpinx in a Virgin Patient with Mayer-Rokitansky-Küster-Hauser Syndrome: Report of a Rare Condition and Its Possible Etiology by Kondo, Eiji, MD, PhD, Tabata, Tsutomu, MD, PhD, Shiozaki, Takaya, MD, Motohashi, Takashi, MD, Tanida, Koji, MD, Okugawa, Toshiharu, MD, PhD, Ikeda, Tomoaki, MD, PhD

“…Abstract Background To describe a rare case of hydrosalpinx torsion in a virgin patient with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. Case A 25-year-old…”
Get full text

Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst by Yoshida, Atsushi, Murabayashi, Nao, Shiozaki, Takaya, Okugawa, Toshiharu, Tabata, Tsutomu

“…The teratoma of the greater omentum is a very rare entity. We present a case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst. The…”
Get full text

A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix by Tabata, Tsutomu, Nishiura, Keisuke, Yanoh, Kenji, Okugawa, Toshiharu, Obata, Hidenori, Tanaka, Keisuke, Toyoda, Nagayasu

“…To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with…”
Get full text

Treatment of venous thromboembolism in cancer patients by Okugawa, Toshiharu, Tabata, Tsutomu, Yamada, Norikazu

Get more information

Does Vaginal Cuff Creation and Avoidance of a Uterine Manipulator Improve the Prognosis of Total Laparoscopic Radical Hysterectomy for Early Cervical Cancer? A Retrospective Multicenter Study by Kondo, Eiji, Yoshida, Kenta, Kubo-Kaneda, Michiko, Nii, Masafumi, Okamoto, Kota, Magawa, Shoichi, Nimua, Ryo, Okumura, Asumi, Okugawa, Toshiharu, Yamawaki, Takaharu, Nagao, Kenji, Yoshimura, Kouichi, Watashige, Naoki, Yanoh, Kenji, Ikeda, Tomoaki

“…Our goal was to compare the treatment outcomes of open-abdominal radical hysterectomy (O-RH) and total laparoscopic hysterectomy (TLRH) with vaginal cuff…”
Get full text

Preoperative management of patients with gynecologic malignancy complicated by existing venous thromboembolism by Shiozaki, Takaya, Tabata, Tsutomu, Motohashi, Takashi, Kondo, Eiji, Tanida, Kouji, Okugawa, Toshiharu, Ikeda, Tomoaki

“…Abstract Objectives In treating gynecologic malignancies, we sometimes encounter patients in whom venous thromboembolism (VTE) has developed before surgery…”
Get full text

Changes of hemostatic molecular markers after gynecological surgery by Noda, K, Wada, H, Yamada, N, Noda, N, Gabazza, E C, Kumeda, K, Okugawa, T, Yanoh, K, Ito, M, Nakano, T, Shiku, H, Nobori, T, Kato, H, Toyoda, N

“…The authors evaluated the hemostatic abnormalities occurring in the postoperative period of eight patients with malignant tumors and compared them with those…”
Get more information

Efficacy of a sodium hyaluronate-carboxycellulose membrane (seprafilm) for reducing the risk of early postoperative small bowel obstruction in patients with gynecologic malignancies by Tabata, Tsutomu, Kihira, Tomohisa, Shiozaki, Takaya, Tanida, Kouji, Kondo, Eiji, Nagao, Kenji, Okugawa, Toshiharu, Sagawa, Norimasa

“…To evaluate the effect of a sodium hyaluronate and carboxymethylcellulose membrane (Seprafilm) on early postoperative small bowel obstruction (EPSBO) in…”
Get more information

A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications by Shiozaki, Takaya, Tabata, Tsutomu, Toriyabe, Kuniaki, Motohashi, Takashi, Kondo, Eiji, Tanida, Kouji, Okugawa, Toshiharu, Sagawa, Norimasa

“…The authors report a case of usual-type (basaloid-type) vulvar intraepithelial neoplasia (VIN) 3 that failed to respond to imiquimod cream. A 51-year-old…”
Get full text

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes by Ikuta, Y, Okugawa, T, Furugen, R, Nagata, Y, Takahashi, Y, Wang, L, Ikeda, H, Watanabe, M, Imai, S, Shiku, H

“…We have identified an H-2K(d)-binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2-specific murine cytotoxic T…”
Get full text

A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals by Okugawa, T, Ikuta, Y, Takahashi, Y, Obata, H, Tanida, K, Watanabe, M, Imai, S, Furugen, R, Nagata, Y, Toyoda, N, Shiku, H

“…A mouse HER2-derived peptide, HER2p63 (A) (TYLPANASL), can induce K(d)-restricted mouse cytotoxic T lymphocytes (CTL) and also function as a tumor rejection…”
Get full text

Development of a cancer vaccine : peptides, proteins, and DNA by SHIKU, H, LIJIE WANG, IKUTA, Y, OKUGAWA, T, SCHMITT, M, XIAOGANG GU, AKIYOSHI, K, SUNAMOTO, J, NAKAMURA, H

“…Genetic changes leading to protooncogene activation qualitatively and/or quantitatively alter their gene products and are exclusively or largely restricted to…”
Get full text

A HER2/neu-derived peptide, a K super(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8 super(+) cytotoxic T lymphocytes by Ikuta, Yasushi, Okugawa, Toshiharu, Furugen, Reiko, Nagata, Yasuhiro, Takahashi, Yoshiyuki, Wang, Lijie, Ikeda, Hiroaki, Watanabe, Masato, Imai, Shigemi, Shiku, Hiroshi

“…We have identified an H-2K super(d)-binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2-specific murine cytotoxic…”
Get full text

A novel human HER2‐derived peptide homologous to the mouse Kd‐restricted tumor rejection antigen can induce HLA‐A24‐restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals by Okugawa, Toshiharu, Ikuta, Yasushi, Takahashi, Yoshiyuki, Obata, Hidenori, Tanida, Koji, Watanabe, Masato, Imai, Shigemi, Furugen, Reiko, Nagata, Yasuhiro, Toyoda, Nagayasu, Shiku, Hiroshi

“…A mouse HER2‐derived peptide, HER2p63 (A) (TYLPANASL), can induce Kd‐restricted mouse cytotoxic T lymphocytes (CTL) and also function as a tumor rejection…”
Get full text

A HER2/NEU‐derived peptide, a Kd‐restricted murine tumor rejection antigen, induces HER2‐specific HLA‐A2402‐restricted CD8+ cytotoxic T lymphocytes by Ikuta, Yasushi, Okugawa, Toshiharu, Furugen, Reiko, Nagata, Yasuhiro, Takahashi, Yoshiyuki, Wang, Lijie, Ikeda, Hiroaki, Watanabe, Masato, Imai, Shigemi, Shiku, Hiroshi

“…We have identified an H‐2Kd‐binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2‐specific murine cytotoxic T…”
Get full text